Skip to main content
Caplight Logo









Neoncorte Bio

Neoncorte Bio

Private
Sheridan, WyomingHealthcare & Life Scienceshttps://neoncorte.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neoncorte Bio is a biotechnology company that offers a suite of AI-powered solutions for enzyme engineering, protein engineering, aptamer design, and antibody discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

protein engineeringenzyme optimizationaptamer discoverydrug discoveryprotein language modelsantibody discoverybiotech aiin silico designbiocatalyst developmenttherapeutic protein engineeringinverse foldinggenerative biologycontract research organizationCROlab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neoncorte Bio Comparables

Compare Neoncorte Bio with similar companies based on industry and business-model similarity.

Neoncorte Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomatter
81%
Ardigen
78%
Cradle
77%

Neoncorte Bio Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Vladimir Shibanov

CMO co-founder - AI-driven aptamer design, protein & enzyme engineering, software development

Founding Team

Neoncorte Bio Investors

Notable investors and investment history

Neoncorte Bio investors
InvestorRounds
Nvidia InceptionAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 184% MoM, reaching 3.6K.

  • Aug 21, 2026

    Monthly visitors grew 104% MoM, reaching 1.3K.

Neoncorte Bio Filings

Explore SEC and related filing metadata, where available.

Neoncorte Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neoncorte Bio's valuation, stock price, and market status.

Is Neoncorte Bio a public or private company?

Neoncorte Bio is a private company.

What is the current stock price of Neoncorte Bio?

Neoncorte Bio is a private company, so its shares have no public market price. Caplight tracks Neoncorte Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Neoncorte Bio worth (valuation)?

Valuation information for Neoncorte Bio is not publicly available.

Can I buy Neoncorte Bio stock?

Neoncorte Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Neoncorte Bio's last funding round?

Funding round information for Neoncorte Bio is not publicly available.

Who are the main investors in Neoncorte Bio?

Key investors in Neoncorte Bio include Nvidia Inception.

Will Neoncorte Bio IPO soon?

No public IPO plans have been announced for Neoncorte Bio.

How can I track Neoncorte Bio secondary market activity?

Caplight tracks bids, offers, and trades in Neoncorte Bio's shares on secondary markets.

Firmographic Details

HeadquartersSheridan, Wyoming
Employee Range3
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?